FDA clears XACT Robotic System for percutaneous interventional procedures

XACT Robotics of Hingham, MA, and Caesarea, Israel has announced that the XACT Robotic System has been cleared by the U.S. Food and Drug Administration (FDA) for use during computed tomography (CT)-guided percutaneous interventional procedures. The system will be introduced in the United States at the 2019 Radiological Society of North America (RSNA) annual meeting in December.

The product is a hands-free robotic system combining image-based planning and navigation with insertion and steering of various instruments to a desired target across an array of clinical applications and indications. It has a small footprint and high mobility design, the company said, and is designed to enable interventional radiologists to reach very small targets with precision accuracy.